The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.460
-0.120 (-7.59%)
At close: Dec 5, 2025, 4:00 PM EST
1.494
+0.034 (2.30%)
After-hours: Dec 5, 2025, 7:58 PM EST
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for The Beauty Health Company stock have an average target of 2.42, with a low estimate of 1.25 and a high estimate of 3.50. The average target predicts an increase of 65.75% from the current stock price of 1.46.
Analyst Consensus: Buy
* Price targets were last updated on Sep 22, 2025.
Analyst Ratings
The average analyst rating for The Beauty Health Company stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $2 → $2.5 | Hold | Maintains | $2 → $2.5 | +71.23% | Sep 22, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +139.73% | Sep 19, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.5 → $1.25 | Hold | Maintains | $1.5 → $1.25 | -14.38% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | +2.74% | Mar 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.25 → $1.75 | Hold | Maintains | $1.25 → $1.75 | +19.86% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
302.59M
from 334.29M
Decreased by -9.48%
Revenue Next Year
315.60M
from 302.59M
Increased by 4.30%
EPS This Year
-0.08
from -0.36
EPS Next Year
-0.09
from -0.08
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 314.3M | 347.6M | ||
| Avg | 302.6M | 315.6M | ||
| Low | 289.1M | 292.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -6.0% | 14.9% | ||
| Avg | -9.5% | 4.3% | ||
| Low | -13.5% | -3.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.07 | 0.11 | ||
| Avg | -0.08 | -0.09 | ||
| Low | -0.09 | -0.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.